2023
335) Bauer, N.; Yang, X.; Yuan, Z.; Wang, B. “Reassessing CORM-A1: redox chemistry and idiosyncratic CO-releasing characteristics of the widely used carbon monoxide donor” Chem. Sci. 2023, in press: https://doi.org/10.1039/D1SC03832J
334) Yang, X.; Tripathi, R.; Wang, M.; Lu, W.; Anifowose, A.; Tan, C.; Wang, B. “Toward “CO in a pill:” Silica-immobilized Organic CO Prodrugs for Studying the Feasibility of Systemic Delivery of CO via in situ Gastrointestinal CO release” Mol. Pharmaceutics 2023, in press: https://doi.org/10.1021/acs.molpharmaceut.2c01104.
333) Wang, B.; Du, Y-C. N. “The anti-metastasis effect of low-dose CO” Ann. Pancr. Cancer 2023, manuscript accepted: doi: 10.21037/apc-2022-4.
332) Kondengadan, M.S.; Bansal, S; Yang, C.; Liu, D.; Fultz, Z.; and Wang, B. “Click Chemistry and Drug Delivery: A Bird’s-eye View” 2023, published on-line: https://doi.org/10.1016/j.apsb.2022.10.015
331) Dong, R.; Yang, X.; Wang, B., and Ji, X. “Mutual Leveraging of Proximity Effects and Click Chemistry in Chemical Biology” Med. Res. Rev. 2023, published on-line, doi: 10.1002/med.21927.
330) Yang, X.; Yuan, Z.; Lu, W.; Yang, C.; Wang, M.; Tripathi, R.; Fultz, Z.; Tan, C.; and Wang, B. “De Novo Construction of Fluorophores via CO Insertion-initiated Lactamization: A Chemical Strategy Towards Highly Sensitive and Highly Selective Turn-on Fluorescent Probes for Carbon Monoxide” J. Am. Chem. Soc. 2023, 145, 78-88. PMID: 36548940
Manuscripts in Preparation (2023)
346) De La Cruz, K.; Lu, W.; Ghorpade, R.; Yang, X.; and Wang, B. “CO Production from a-Ketoacids using Immobilized Catalysts” 2023, manuscript in preparation
345) Yang, X.; Lu, W.; Luo, M.; Kumar, M.; and Wang, B. “Inhibitors of Membrane Fusion: New Antiviral Agents” 2023 manuscript in preparation
344) Yu, B.; Yuan, Z.; Yang, X.; Wang, B. “The Elephant in Sulfur Signaling: Its Redox Chemistry” Med. Res. Rev. 2023, manuscript in preparation
343) Yang, X.; Lu, W.; and Wang, B. “CO Prodrug Activation by pH-sensitive Enolization” 2023 manuscript in preparation
342) Yang, X.; Liu, D.; Lu, W.; and Wang, B. “Carbon Monoxide Does Not Activate HO-1 in Cell Culture” 2023 manuscript in preparation
341) Liu, D.; Yang, X.; and Wang, B. “Sensing a CO-releasing Molecule (CORM) Does Not Equate to Sensing CO: The Case of DPHP” 2023, manuscript in preparation
340) Kondengadan, M.S.; Bansal, S.; Chaudhury, M.; and Wang, B. “Redox-sensitive Linkers for Drug Delivery Applications” 2023, manuscript in preparation
339) Tripathi, R.; Guglani, A.; Ghorpade, R.; and Wang, B. “Biotin-mediated Drug Delivery and Labeling: Is It Simply through Transporter Mediated? 2023, manuscript in preparation
338) Yang, C.; Tripathi, R. and Wang, B. “The Application of Click Chemistry to Enable Development of PROTACs” 2023, manuscript in preparation.
337) Yang, X.; Liu, D.; and Wang, B. “Let CO Shine: Fluorescent Probes for Sensing, Detection, and Quantification of CO” 2023, manuscript in preparation
336) Bauer, N.; Yuan, Z.; Yang, X.; Wang, B. “The Chemical Reactivity, CO-independent Biological Activity, and Unreliable CO-donating Characteristics of Four Most Commonly Used CO-releasing Molecules for Studying CO Biology: CORM-2, CORM-3, CORM-401, and CORM-A1” 2023, manuscript in preparation
2022
329) Wang, B. “Nucleic Acid-based Therapeutics: A Tour de Force,” a Preface for “Medicinal Chemistry of Nucleic Acid” 2022, Zhang, L.; Tang, X.; Xi, Z.; and Chattopadhyya, J. Editors, John Wiley and Sons, New Jersey, in “Wiley Series in Drug Discovery and Development” Wang, B, Serial Editor. ISBN: 978-1-119-69274-4
328) Tripathi, R.; Anifowose, A.; Lu, W.; Yang, X.; and Wang, B. “Upregulation of p53 through Induction of MDM2 Degradation: Improved Potency through the Introduction of an Alkylketone Sidechain on the Anthraquinone Core” J. Enzy. Inhib. Drug Design 2022, 37, 2370-2381.
327) De La Cruz, L.K.; Bauer, N.; Cachuela, A.; Tam, S. Tripathi, R. Yang, X.; Wang, B. “Light-activated CO donor as a Universal CO Surrogate for Pd-catalyzed and Light-mediated Carbonylation ” Org. Lett. 2022, 24, 4902-4907.
326) Yu, B.; Choudhury, M.R.; Yang, X.; Benoit, S.L.; Womack, E.; Acharya, A.; Kumar, A.; Yang, C.; Pavlova, A.; Zhu, M.; Yuan, Z.; Gumbart, J.C. Boykin, D.W.; Maier, R.J.; Eichenbaum, Z.; Wang, B. “Restoring and enhancing the potency of existing antibiotics against drug-resistant Gram-negative bacteria through the development of potent small-molecule adjuvants” ACS Infec. Disease 2022, 8, 1491-1508.
325) Yang, X.; De La Cruz, L.K.; Yuan, Z.; and Wang, B. “Carbon Monoxide Signaling: Examining Its Engagement with Various Molecular Targets in the Context of Binding Affinity, Concentration, and Biologic Response” Pharmacol. Rev., 2022, 74, 823-873. PMID: 35738683, PMCID: PMC9553107
324) Lu, W.; Yang, X.; Wang, B. “Carbon Monoxide Signaling and Soluble Guanylyl Cyclase: Facts, Myths, and Intriguing Possibilities” Biochem. Pharmacol. 2022, 200, 115041. PMID: 35447132
323) Yang, X.; Lu, W.; Wang, M.; Tan, C.; Wang, B. “Activated Charcoal Dispersion of Carbon Monoxide Prodrugs for Oral Delivery of CO in a Pill” Int. J. Pharm. 2022, 618, 121650. PMID: 35276229, PMCID: PMC9060424
322) Yu, B.; Yuan, Z.; Wang, B. “Persulfide Prodrugs” in “Hydrogen Sulfide: Chemical Biology and Applications.” Pluth M. Editor, John Wiley and Sons, New Jersey, as part of the “Wiley series in Drug Discovery and Development” with Wang, B. as the serial editor; John Wiley and Sons, Hoboken, New Jersey, 2022, ISBN: 9781119799870
321) Wang, B and Otterbein, L.E. “Carbon Monoxide: Promises and challenges in its pharmaceutical development,” in “Carbon Monoxide in Drug Discovery: Basics, Pharmacology, and Therapeutic Potential,” Wang, B. and Otterbein, L.E. Editors; as part of the “Wiley Series in Drug Discovery and Development,” Wang, B. Serial Editor; John Wiley and Sons, Hoboken, New Jersey, 2022: A preface. P1-2. ISBN: 9781119783404
320) De La Cruz, L.K. and Wang, B. “Carbon Monoxide Production: In health and in sickness” in “Carbon Monoxide in Drug Discovery: Basics, Pharmacology, and Therapeutic Potential,” Wang, B. and Otterbein, L.E. Editors; as part of the “Wiley Series in Drug Discovery and Development,” Wang, B. Serial Editor; John Wiley and Sons, Hoboken, New Jersey, 2022, p302-318. ISBN: 9781119783404
319) Yuan, Z and Wang, B. “Organic carbon monoxide prodrugs that release CO under physiological conditions” in “Carbon Monoxide in Drug Discovery: Basics, Pharmacology, and Therapeutic Potential,” Wang, B. and Otterbein, L.E. Editors, as part of the “Wiley Series in Drug Discovery and Development,” Wang, B. Serial Editor; John Wiley and Sons, Hoboken, New Jersey, 2022, p232-258. ISBN: 9781119783404
318) Yang, X.; Wang, M.; Tan, C.; Lu, W.; and Wang, B. “Pharmacokinetics of Carbon Monoxide” in “Carbon Monoxide in Drug Discovery: Basics, Pharmacology, and Therapeutic Potential,” Wang, B. and Otterbein, L.E. Editors, as part of the “Wiley Series in Drug Discovery and Development,” Wang, B. Serial Editor; John Wiley and Sons, Hoboken, New Jersey, 2022, p44-87. ISBN: 9781119783404
317) De La Cruz, L.K. and Wang, B. “Natural products that generate carbon monoxide: Its chemistry and nutritional implications” in “Carbon Monoxide in Drug Discovery: Basics, Pharmacology, and Therapeutic Potential,” Wang, B. and Otterbein, L.E. Editors, as part of the “Wiley Series in Drug Discovery and Development,” Wang, B. Serial Editor; John Wiley and Sons, Hoboken, New Jersey, 2022, p3-26. ISBN: 9781119783404
2021
316) El-labbad, E.M.; Ji, X.; Abouzid, K.A.M.; Wang, B. “Medicinal Chemistry Strategies Towards SO2 Donors as Research Tools and Potential Therapeutics” Topics Current Med. Chem. 2021, 21, 2870-2881. PMID: 34784869
315) Tripathi, R.; Yang, X.; Ryter, S.W.; Wang, B. “Carbon Monoxide as a Therapeutic for Airway Diseases: Contrast and Comparison of Various CO Delivery Modalities” Topics Current Med. Chem. 2021, 21, 2890-2908. PMID: 34784868.
314) Yuan, Z.; Yang, X.; Wang, B. “Redox and catalase-like activities of four widely used carbon monoxide releasing molecules (CO-RMs)” Chem. Sci. 2021, 12, 13013-13020.
313) Yang, X.; Lu, W.; Wang, M.; Tan, C.; Wang, B. “‘CO in a Pill:’ Towards Oral Delivery of Carbon Monoxide for Therapeutic applications” J. Controlled Release, 2021, 338, 593-609. PMID: 34481027
312) De La Cruz, L.K.; Yang. X.; Menshikh, A.; Lu, W.; Wang, M.; Wang, S.; Ji, X.; Cachuela, A.; Yang, C.; Gallo, D.; Tan, C.; Otterbein, L.E.; De Caestecker, M.; Wang, B. “Adapting decarbonylation chemistry for the in-vivo delivery of carbon monoxide through prodrug preparation utilizing sweetener as carrier molecule” Chem. Sci. 2021, 12, 10649-10654. PMID: 34447558, PMCID: PMC8356820
311) De La Cruz, L.K.; Ji, X.; Yang, X.; Wang, B. “Click, release, and fluoresce: in-vivo generation of CO with concomitant synthesis of a fluorescent reporter” Bioorg. Med. Chem. 2021, 44, 316297.
310) Bakalarz, D.; Korbut, E.; Yuan, Z.; Yu, B.; Wojcik, D.; Danielak, A.; Magierowska, K.; Kwiecien, S. Brzozowski, T.; Marcinkowska, M.; Wang, B.; Magierowski, M. “Novel hydrogen sulfide (H2S)-releasing BW-HS-101 and its non-H2S releasing derivative in modulation of microscopic and molecular parameters of gastric mucosal barrier” Int. J. Mol. Sci. 2021, 22, 5211. https://doi.org/10.3390/ijms22105211
309) Bhattarail, N.; Wang, J.; Nguyen, D.; Yang, X.; Helmers, L.; Paruch, J.; Li, L.; Zhang, Y.; Meng, K.; Wang, A.; Jayawickramarajah, J. Wang, B.; and Lu, H. “Nanoparticle Encapsulation of Non-genotoxic p53 Activator Inauhzin-C for Improved Therapeutic Efficacy.” Theranostics, 2021,11, 7005-7017.
308) Jin, S.; Chaudhary, A.S.; Hsieh, Y.-H.; Wang, B.; Tai, P.C. “Thiouracil SecA inhibitors: Bypassing the effects of efflux pumps and attenuating virulence factor secretion in MRSA and Bacillus anthracis” Med. Chem. Res. 2021, 30, 1341-1347.
307) Bamba, F.; Ji, J.; Chaudhary, A.S.; Tai, P.C.; and Wang, B. “Design, synthesis and biological evaluation of pyrimidine analogues as SecA inhibitors” Med. Chem. Res. 2021, 30, 1334-1340.
306) Yuan, Z.; Yang, X.; Ye, Y.; and Wang, B. “Chemical Reactivities of two widely used ruthenium-based CO releasing molecules (CO-RMs) with a range of biologically important reagents and molecules” Anal. Chem. 2021, 93, 5317-5326. PMID:33745269.
305) Yang, X.; Hopper, C.; Lu, W.; Ke, B.; Wang, B. “Nature’s Marvels Endowed in Gaseous Molecules I: The Example of Carbon Monoxide as An Endogenous Signaling Molecule and A Potential Therapeutic Agent” Acta Pharm. Sinica B. 2021, 11, 1434-1445.
2020
304) Bakalarz, D.; Surmiak, M.; Wójcik, D.; Yang, X.; Edyta, K.; Pan, Z.; Śliwowski, Z.; De La Cruz, L. K.; Ginter, G. Buszewicz, G.; Brzozowski, T.; Cieszkowski, J.; Głowacka, U.; Magierowska, K. Wang, B.; Magierowski, M. “Organic carbon monoxide prodrug, BW-CO-111, in protection against chemically-induced gastric mucosal damage.” Acta Pharm. Sinica B. 2021, 11, 456-475.
303) Hopper, C.; De La Cruz, L.K.; Lyles, K.; Wareham, L.; Gilbert, J.A.; Eichenbaum, Z.; Magierowski, M.; Poole, R.K.; Wollborn, J.; Wang, B. “The Role of Carbon Monoxide in Host-Gut Microbiome Communication” Chem. Rev. 2020, 120, 13273-13311. PMID: 33089988
302) Yang, X.; Pan, Z.; Chaudhury, M.; Anifowose, A.; Yuan, Z.; Yu, B.; Wang, W.; Wang, B. “Making smart drugs smarter: The importance of linker chemistry in targeted drug delivery” Med. Res. Rev. 2020, 40, 2682-2713. PMID: 32803765
301) Yu, B.; Yuan, Z.; Yang, X.; Wang, B. “Prodrugs of Persulfide, SO2, and CS2: Important Tools for Studying Sulfur Signaling at Various Oxidation States” Antioxidant Redox Signal. 2020, 33, 1046-1059. PMID: 32041416
300) Wang, M.; Yang, X.; Pan, Z.; Wang, Y.; De La Cruz, L.K.; Wang, B.; Tan, C. “Towards “CO in a Pill”: Pharmacokinetic Studies of Carbon Monoxide Prodrugs in Mice” J. Control. Release 2020, 327, 174-185. PMID: 32745568
299) Anifowose, A.; Agbowuro, A.; Tripathy, R.; Lu, W.; Tan, C.; Yang, X.; Wang, B. “Inducing Apoptosis through Upregulation of p53: Structure-Activity Exploration of Anthraquinone Analogs” Med. Chem. Res. 2020, 29, 1199-1210.
298) Anifowose, A.; Agbowuro, A.; Yang, X.; Wang, B “Anticancer Strategies by Upregulating p53 through Inhibition of its Ubiquitination by MDM2” Med. Chem. Res. 2020, 29, 1105-1121.
297) Wang, S.; Hu, L.; Wang, B. “In Honor of Professor Robert P. Hanzlik on the Occasion of His Retirement” (Editorial) Med. Chem. Res. 2020, 29, 1091-1092.
296) Bamba, F.; Jin, J.; Tai, PC, Wang, B. “Synthesis and Biological Evaluation of 4-oxo-5-cyano Thiouracil Derivatives as SecA Inhibitors” Heterocyclic Commun. 2020, 26, 76-83.
295) Huang, Z.; Wang, B. “Gaseous Signaling Molecules as Potential Therapeutic Agents” (Editorial) Chin. J. Natural Med. 2020, 18, 273-274.
294) Zheng, Y.; Yuan, Z.; Wang, B. “Prodrugs of Hydrogen Sulfide and Related Species: Recent Development” Chin. J. Natural Med. 2020, 18, 296-307.
293) Yang, X.; Ke, B.; Lu, W.; Wang, B. “CO as a Therapeutic Agent: Discovery and Delivery Forms” Chin. J. Natural Med. 2020, 18, 284-295.
292) Liao, P.; Cao, B.; Zhou, X.; Jung, J.H.; Damera, K.; Fuseller, T.; Thareja, S.; Wimley, C.W.; Wang, B.; Zeng, S.; Lu, H. “Crotinylation at Serine 46 Impairs p53 Activity” Biochem. Biophys. Res. Commun. 2020, 524, 730-735. PMID: 32035620
291) Yang, X.; De Caestecker, M.; Otterbein, L.E.; Wang, B. “Carbon Monoxide: An Emerging Therapeutic Agent for Acute Kidney Injury” Med. Res. Rev. 2020, 40, 1147-1177. PMID: 31820474
290) Wang, B. “The Past 20 Years of Medicinal Research Reviews” (Editorial) Med. Res. Rev. 2020, 40, 1-2
289) Yuan, Z.; Yang, X.; De La Cruz, L.K.; Wang, B. “Nitro Reduction-based Fluorescent Probes for Carbon Monoxide Require Reactivity Involving a Ruthenium Carbonyl Moiety” Chem. Commun. 2020, 56, 2190-2193. PMID: 31971171, PMCID:
288) Anifowose, A.; Yuan Z.; De La Cruz, K.; Yang, X.; Wang, B. “Upregulation of p53 through Induction of MDM2 Degradation: Amino Acid Prodrugs of Anthraquinone Analogs” Bioorg. Med. Chem. Lett. 2020, 30, 126786. PMID: 31753697, PMCID: PMC6942214
2019
287) Draganov, A.; Dai, C.; Ni, N.; Chen, W.; De Los Santos, Z. Anifowose, A.; De La Cruz, K.; Yang, X.; Wang, B. “Upregulation of p53 through Induction of MDM2 Degradation: Anthraquinone Analogs” Bioorg. Med. Chem., 2019, 27, 3860-3865. PMID: 31324563.
286) Sun, X.; Chapin, B.M.; Metola, P.; Collins, B.; Wang, B.; James, T.D.; Anslyn, E.V “The mechanisms of boronate ester formation and fluorescent turn-on in ortho-aminomethylphenylboronic acids” Nature Chem. 2019, 11, 768-778. PMID: 31444486
285) Ji, X.; Aghoghovbia, R.E.; De La Cruz, L.K.C.; Ji, K.; Pan, Z.; Yu, B.; Yang, L.; Wang, B. “Click and release: A high-content bioorthogonal prodrug with multiple outputs” Org. Lett. 2019, 31, 3649-3652. PMID: 31063383
284) Sun, X.; Chapin, B.M.; Metola, P.; Collins, B.; Wang, B.; James, T.D.; Anslyn, E.V “A Treatise Concerning the Mechanisms of Boronate Ester Formation and Fluorescent Turn-on in ortho-Aminomethyl Phenyl Boronic Acids” Nature Chem. 2019, manuscript accepted pending minor revisions.
283) Ji. X.; Wang, B. “Click and Release: Bioorthogonal Approaches to the “on-demand” Activation of Prodrugs” Chem. Soc. Rev. 2019, invited manuscript accepted pending typographic revisions.
282) Dong, L.; You, S.; Zhang, Q.; Osuka, S.; Devi, N.S.; Kaluz, S.; Ferguson, J.N.H.; Yang, H.; Chen, G.; Wang, B.; Grossniklaus, H.E.; Van Meir, E. “Arylsulfonamide 64B inhibits hypoxia/HIF-induced expression of c-Met and CXCR4 and reduces tumor growth and metastasis of uveal melanoma” Clin. Cancer Res. 2019, 10.1158/1078-0432.CCR-18-1368.
2018
281) Zheng, Y.; Yu, B.; De La Cruz, L.K.; Chaudhary, M.; Anifowose, A. “Toward Hydrogen Sulfide–Based Therapeutics: Critical Drug Delivery and Developability Issues” Med. Res. Rev., 2018, 38, 57-100. PMID: 28240384
280) Qiao, D.; Shen, T.; Zhu, M.; Liang, X.; Zhang, L.; Yin, Z.; Wang, B.; Shang, L. “A highly selective and sensitive fluorescent probe for simultaneously distinguishing and sequentially detecting multiple thiol species in solution and in vitro” Chem. Commun. 2018, 54, 13252-13255.
279) Ji, X.; Pan, Z.; Zhang, J.; Ji, K.; Chittavong, V.; Wang, B. “Organic CO prodrugs activated by endogenous ROS” Org. Lett. 2018, 20, 8-11.
278) Yu, B.; Zheng, Y.; Yuan, Z.; Li, S.; Zhu, H.; De La Cruz, L. K.; Zhang, J.; Ji, K.; Wang, S.; Wang, B. “Toward Direct Protein S-Persulfidation: A Prodrug Approach that Directly Delivers Hydrogen Persulfide” J. Am. Chem. Soc. 2018, 140, 30-33. PMID: 29211467
277) De La Cruz, K; Benoit, S.; Pan, Z.; Yu, B.; Maier, R.; Ji, X.; Wang, B. “Click, release, and fluoresce: a cascade prodrug for co-delivery of carbon monoxide, a drug payload, and a fluorescent reporter” Org. Lett. 2018, 20, 897-900. PMID: 29380605
276) Gu, L.; Zhang, H.; Liu, T.; Draganov, A.B.; Yi, S.; Wang, B.; Zhou, M. “Inhibition of MDM2 by a rhein-derived compound AQ-101 suppresses cancer development in SCID mice” Mol. Cancer Therap. 2018, 17, 497-507.
275) Zheng, Y.; Ji, X.; Yu, B.; Ji, K.; Gallo, D.; Csizmadia, E. Zhu, M.; De La Cruz, L.K.; Choudhary, M.R.; Chittavong, V.; Pan, Z.; Yuan, Z.; Otterbein, L.; Wang, B. “Enrichment-triggered Prodrug Activation Demonstrated through Mitochondria-targeted Delivery of Doxorubicin and Carbon Monoxide” Nature Chem. 2018, 10, 787-794. PMID: 29760413, PMCID: PMC6235738
274) Xin, M.; Ji, X.; De La Cruz, L.K.C.; Thareja, S.; Wang, B. “Strategies to Target the Hedgehog Signaling Pathway for Cancer Therapy” Med. Res. Rev. 2018, 38, 870-913.
273) Correa-Costa, M.; Gallo, D.; Csizmadia, E.; Ji, X.; Lieberum, J.-L.; Hauser, C.J.; Wang, B.; Camara, N.O.S.; Robson, S.C.; Otterbein, L. E. “Carbon monoxide protects the kidney through the central circadian clock and CD39” Proc. Natl. Acad. Sci. 2018, 115, E2302-E2310.
272) Cao, J.; Zang, J.; Ma, C.; Li, X.; Hou, J.; Li, J.; Huang, Y.; Xu, W.; Wang, B. Zhang, Y. “Design, Synthesis and Biological Evaluation of New Pyrazoline-Based Hydroxamic Acid Derivatives as Aminopeptidase N (APN) Inhibitors” ChemMedChem, 2018, 13, 431-436.
271) Ji. X.; Wang, B. “Strategies towards Organic Carbon Monoxide Prodrugs” Acc. Chem. Res. 2018, 51, 1377-85.
270) Zhang, J.; Lu, W.; Shan, Y.; Wang, B. “Novel Strategies in the Discovery of Anti-angiogenesis Agents: Multiplex Inhibitors Suppressing the Compensatory Activation of RTKs and Vascular Normalization” Med. Res. Rev. 2018, 38, 1674-1701.
269) Jin, J.; Hsieh, Y.; Chaudhary, A.; Cui, J.; Houghton, J.; Sui, S.; Wang, B. Tai, PC. “SecA inhibitors as potential antimicrobial agents: differential actions on SecA-only and SecA-SecYEG protein-conducting channels” FEMS Microbiol. Lett. 2018, 365, doi: 10.1093/femsle/fny145
268) Yu, B.; Li, S.; Wang, J.; Wang, J.; Zheng, Y.; Zhang, H.; Walker, M.J.; Yuan, Z.; Zhu, H.; Zhang, J.; Wang, P.G.; Wang. B. “Biomarker-based Metabolic Labeling for Redirected and Enhanced Immune Response” ACS Chem. Biol. 2018, 13, 1686-1694. PMID: 29792670
267) Cao, J.; Ma, C.; Zang, J.; Gao, S.; Gao, Q.; Kong, X.; Yan, Y.; Lian, X.; Ding, Q.; Zhao, C.; Wang, B.; Xu, W.; Zhang, Y. “Novel leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry” Bioorg. Med. Chem. 2018, 26, 3145-3157.
266) Yuan, Z.; Zheng, Y.; Yu, B.; Wang, S.; Yang, X.; Wang, B. “An Esterase-sensitive Glutathione Persulfide Donor” Org. Lett. 2018, 20, 6364-6367. PMID: 30299967
265) Ma, Y.; Shang, C.; Yang, P.; Li, L.; Zhai, Y.; Yin, Zheng, Y.; Wang. B. Shang, L. “4-Iminooxazolidin-2-one as a bioisostere of the cyanohydrin moiety: inhibitors of enterovirus 71 3C protease” J. Med. Chem. 2018, 61, 10333-10339.
264) Wang, W.; Wang, B. “Sulfur Dioxide Donors and Prodrugs, and Their Possible Applications: A Review” Front. Chem. 2018, doi.org/10.3389/fchem.2018.00559